NVE Reports 81% Revenue Jump, Declares $1 Dividend Amid Strategic Leadership Changes

NVE disclosed an ongoing leadership transition with Pete Eames identified as successor CEO and a plan to expand the board, alongside CEO Daniel A. Baker and CFO Daniel Nelson on the earnings call.
NVE filed its Form 10-Q for the quarter ended June 30 and highlighted prior announcements of noninvasive hemoglobin measurement research using an NVE sensor, including a study published in the AIP Conference Proceedings and a separate Arduino-based noninvasive testing approach.
Beyond the core results, market data cited in independent coverage shows NVE carrying a debt-to-equity ratio of 0.02 and a current market capitalization around $419 million, with a reported P/E of about 27.61x, indicating high valuation relative to historical averages.
Analyst and market commentary from TipRanks notes NVEC as an Outperform and frames the quarter’s strong earnings growth and a sizable dividend as factors that may broaden appeal to both income-focused and growth-oriented investors, while also warning about valuation and earnings volatility.
NVE Corporation posted a stunning 81% jump in revenue for the quarter ended June 30, 2026, bringing in $11.0 million compared to $6.10 million a year earlier, according to MarketScreener. Net income rose 79% to $6.39 million, or $1.32 per diluted share. The board also declared a $1.00 quarterly cash dividend, payable August 31, 2026.
CEO Daniel A. Baker credited strong demand for new products and a healthy semiconductor market for the surge. The results mark one of NVE's strongest quarters in recent memory for the Eden Prairie, Minnesota-based spintronics specialist.
Product sales led the charge, rising 82% year over year, according to MarketScreener. Contract research and development revenue also jumped 53%. Together, those two lines pushed total revenue from $6.10 million to $11.0 million. NVE makes spintronics-based sensors — devices that use electron spin, not just electric charge, to detect magnetic fields.
The company filed its Form 10-Q for the period with the SEC, Traders Union reported. The filing gives investors a detailed look at NVE's operations and finances. NVE also highlighted recent medical research using its sensor technology, including a study on noninvasive hemoglobin measurement published in AIP Conference Proceedings.
The board approved a $1.00 per share quarterly cash dividend. Shareholders of record as of August 3, 2026 will receive the payment on August 31, 2026. NVE carries a debt-to-equity ratio of just 0.02, signaling a nearly debt-free balance sheet. Its current market cap sits around $419 million.
TipRanks rated NVEC as Outperform and noted the sizable dividend may attract both income-focused and growth-oriented investors. The combination of strong earnings growth and a reliable payout could expand NVE's shareholder base going forward.
NVE is in the middle of a leadership change. Pete Eames, currently Vice President of Advanced Technology, has been named successor CEO, according to GuruFocus. Eames joined Baker and CFO Daniel Nelson on the earnings call. The company also plans to expand its board as part of its strategic planning.
Baker did not give a specific timeline for the transition. But the move signals NVE is preparing for its next chapter. Eames's background in advanced technology fits NVE's push to grow its spintronics sensor applications in new markets, including medical devices.
NVE trades at a P/E ratio of about 27.61x, according to TipRanks. That is high relative to NVE's own historical averages. Analysts warn that earnings can swing sharply depending on contract research revenue, which is not always predictable from quarter to quarter.
TipRanks flagged earnings volatility as a key risk for investors. A single large contract can meaningfully boost results, just as its absence can drag them down. Investors should weigh the strong Q1 performance against the possibility that future quarters may not match this pace.
Publishers
12
Articles
15
Reach
27